Scholarlink

Background <p>Vaccine hesitancy is a major public health challenge, particularly during the COVID‑19 pandemic, undermining vaccine uptake and threatening population immunity. Institutional distrust is a key determinant of vaccine hesitancy. Patient-centered communication (PCC) may foster institutional trust and promote vaccine uptake, yet its mechanisms are not fully understood. Building on our proposed dual pathways model, this study aims to explore the underlying process of how PCC directly shapes COVID-19 vaccine uptake, related beliefs, and attitudes, and indirectly shapes these outcomes through trust in health authorities and pharmaceutical companies.</p> Methods <p>Using quota sampling, an online cross-sectional survey of 759 Hong Kong adult residents with recent consultations with healthcare professionals (mean age = 39.47; 53.5% female) was conducted. A parallel mediation analysis was performed using SPSS PROCESS macro Model 4 with bootstrapping.</p> Results <p>PCC was positively and significantly associated with vaccine uptake, perceived personal and social benefits, and favorable vaccination attitudes. It was also positively linked to trust in health authorities and pharmaceutical companies. Furthermore, mediation analyses revealed significant indirect associations between PCC and all vaccination outcomes through trust in health authorities; similarly, significant indirect associations between PCC and all vaccination outcomes were observed via trust in pharmaceutical companies.</p> Conclusion <p>PCC promotes vaccine uptake through direct health decision-making partnership building with healthcare professionals and indirect trust-building in health authorities and pharmaceutical companies. Equipping healthcare professionals with PCC competencies and mobilizing PCC-competent healthcare professionals in vaccination campaigns are likely to enhance vaccine uptake.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Examining the role of patient-centered communication in COVID-19 vaccine uptake

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月25日

查看全文
  • Ho Man Leung,
  • Timothy K. F. Fung

摘要

Background

Vaccine hesitancy is a major public health challenge, particularly during the COVID‑19 pandemic, undermining vaccine uptake and threatening population immunity. Institutional distrust is a key determinant of vaccine hesitancy. Patient-centered communication (PCC) may foster institutional trust and promote vaccine uptake, yet its mechanisms are not fully understood. Building on our proposed dual pathways model, this study aims to explore the underlying process of how PCC directly shapes COVID-19 vaccine uptake, related beliefs, and attitudes, and indirectly shapes these outcomes through trust in health authorities and pharmaceutical companies.

Methods

Using quota sampling, an online cross-sectional survey of 759 Hong Kong adult residents with recent consultations with healthcare professionals (mean age = 39.47; 53.5% female) was conducted. A parallel mediation analysis was performed using SPSS PROCESS macro Model 4 with bootstrapping.

Results

PCC was positively and significantly associated with vaccine uptake, perceived personal and social benefits, and favorable vaccination attitudes. It was also positively linked to trust in health authorities and pharmaceutical companies. Furthermore, mediation analyses revealed significant indirect associations between PCC and all vaccination outcomes through trust in health authorities; similarly, significant indirect associations between PCC and all vaccination outcomes were observed via trust in pharmaceutical companies.

Conclusion

PCC promotes vaccine uptake through direct health decision-making partnership building with healthcare professionals and indirect trust-building in health authorities and pharmaceutical companies. Equipping healthcare professionals with PCC competencies and mobilizing PCC-competent healthcare professionals in vaccination campaigns are likely to enhance vaccine uptake.